Pharmacists in League City, TX Accepting Medicare

56 Pharmacists found. Showing 1 - 20

Dr. Donette Reyne Paige, PHARMD, RPH Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 2750 E League City Pkwy, League City, TX 77573 Phone: 281-521-2561    Fax: 281-521-2563

Kanisha C Frazier, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2965 Terrell Cove Ln, League City, TX 77573 Phone: 630-936-8920

Pamela B Ouzts Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1088 W Main St, League City, TX 77573 Phone: 281-332-3445    Fax: 281-332-3482

Annette Login Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1150 Devereux Dr, League City, TX 77573 Phone: 281-335-1000    Fax: 281-316-5448

Dipu George, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1088 W Main St, League City, TX 77573 Phone: 281-332-3445

Dr. Ashley Hetzer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1295 E League City Pkwy, League City, TX 77573 Phone: 281-332-8290

Julie Stanton, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2955 Gulf Fwy S, League City, TX 77573 Phone: 281-337-5210    Fax: 281-337-5274

Colin Joe Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1088 W Main St League City, Tx 77573 United States, League City, TX 77573 Phone: 281-332-3445

Mrs. Karin Ann Strubbe, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2990 Marina Bay Dr, League City, TX 77573 Phone: 281-535-0254    Fax: 281-538-0077

Mrs. Sonya Lynn Hern, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 Gulf Freeway South, T-2320, League City, TX 77539 Phone: 281-534-5421    Fax: 281-534-5421

Jimmie Gail Andrews-marsh, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1150 Devereux Dr, League City, TX 77573 Phone: 281-335-1000

Doan T Ta, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4902 W Main St, League City, TX 77573 Phone: 281-316-7625

Dr. Saman Mashi, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 502 Tx-3 North, Suite D, League City, TX 77573 Phone: 832-478-2177    Fax: 609-455-1150

Reine Deogracia Yandouma Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2990 Marina Bay Dr, League City, TX 77573 Phone: 281-535-0254

Dr. Kimberly B Brown, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2990 Marina Bay Dr, League City, TX 77573 Phone: 281-535-0254    Fax: 281-535-0077

Melissa Ann Lancon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1150 Devereux Dr, League City, TX 77573 Phone: 281-335-1000

Dr. David Tan Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1088 W Main St, League City, TX 77573 Phone: 281-332-3445    Fax: 281-332-3482

Massiel Marie Perez, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1088 W Main St, League City, TX 77573 Phone: 281-332-3445    Fax: 281-332-3482

Omar Sharfa Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 250 S Egret Bay Blvd, League City, TX 77573 Phone: 281-332-2551    Fax: 281-554-9032

Dr. Sheeba Mathew, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2990 Marina Bay Dr, League City, TX 77573 Phone: 281-535-0254    Fax: 281-535-0077

News Archive

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has licensed an extensive patent estate from the University of Washington and the Fred Hutchinson Cancer Research Center for 25 pending and issued patents related to herpes simplex virus (HSV) type 2 antigens. The addition of these patents complements the novel antigens discovered by Genocea's unique and proprietary antigen discovery technology. The combination of Genocea's novel intellectual property with the patent estate from the University of Washington provides the Company with a broad compendium of HSV antigen patents.

Data demonstrates the effectiveness of NeuroAiD on neuronal and brain injuries

The January issue of "Neuropharmacology", publishes the article entitled "Neuroprotective and Neuroproliferative Activities of NeuroAiD", reporting pharmacological data establishing NeuroAiD (MLC 601) protective effects on neuronal and brain injuries as well as its effectiveness in neurological functions recovery.

Akonni receives $150,000 Phase I NSF grant to assess feasibility of developing lab-on-a-film microarray device

Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated molecular testing devices for diagnosing infectious diseases and human genetic disorders, announced today the receipt of a $150,000 Phase I Grant from the National Science Foundation (NSF). This initial round of funding from NSF will enable Akonni to assess the feasibility of developing a lab-on-a-film microarray device that can be manufactured in a reel-to-reel format.

Drug-incorporated nanoparticle platforms allow for selective targeting of cancer cells

Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. It is a leading cause of death and the burden is expected to grow worldwide due to the growth and aging of the population, mainly in less developed countries, in which about 82% of the world's population resides. By 2030, the global burden is expected to grow to 21.7 million new cancer cases and 13 million cancer deaths simply due to the growth and aging of the population. Current cancer therapy approaches are based in surgery, radiotherapy and chemotherapy, being the chemotherapy the one that shows the greater efficiency for cancer treatment, mainly in more advanced stages. A major problem with this conventional chemotherapy is its toxicity and it also destroys healthy tissues resulting in systemic toxicity besides beneficial characteristics of killing cancer cells. Anticancer drugs also destroy healthy tissues resulting in systemic toxicity.

Septic shock and pneumonia triggered by SARS-CoV-2 could be treated by radiation-activated MSCs

This study, published in the journal Cells, is based on others (all of which employed experimental models) previously conducted by researchers at the Biomedical Research Centre of the University of Granada, the ‘López-Neyra' Institute of Parasitology and Biomedicine, and the ‘Virgen de las Nieves' University Hospital in Granada

Read more Medical News

› Verified 5 days ago

• 1(current)
• 2
• 3